The George Institute for International Health, Renal Division, PO Box 201, Missenden Road, Camperdown, NSW 2050, Australia.
Nephrology (Carlton). 2010 Jun;15(4):429-33. doi: 10.1111/j.1440-1797.2010.01300.x.
Variability in implementing research evidence into clinical practice is widespread, including in the management of patients with kidney disease. There are numerous well-known barriers and facilitators to evidence implementation identified in other clinical settings and a few chronic kidney disease studies. The necessary changes to health systems that support evidence implementation take time to design, apply and to have a measurable effect. Measurement against an agreed standard is fundamental to this process. We use the example of renal anaemia management across a dialysis unit to illustrate an approach to these issues.
将研究证据应用于临床实践中的变异性很普遍,包括对肾病患者的管理。在其他临床环境和一些慢性肾病研究中已经确定了许多众所周知的证据实施障碍和促进因素。支持证据实施的卫生系统必须进行必要的改变,这需要时间来设计、应用和产生可衡量的效果。根据商定的标准进行衡量是这一过程的基础。我们以透析单位的肾脏贫血管理为例,说明解决这些问题的方法。